127 related articles for article (PubMed ID: 21751144)
1. Expression of a putative stem cell marker Musashi-1 in endometrium.
Lu X; Lin F; Fang H; Yang X; Qin L
Histol Histopathol; 2011 Sep; 26(9):1127-33. PubMed ID: 21751144
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of the adult stem cell marker Musashi-1 in endometriosis and endometrial carcinoma.
Götte M; Wolf M; Staebler A; Buchweitz O; Kelsch R; Schüring AN; Kiesel L
J Pathol; 2008 Jul; 215(3):317-29. PubMed ID: 18473332
[TBL] [Abstract][Full Text] [Related]
3. Maspin expression, subcellular localization and clinicopathological correlation in endometrial hyperplasia and endometrial adenocarcinoma.
Blandamura S; Alessandrini L; Saccardi C; Giacomelli L; Fabris A; Borghero A; Litta P
Histol Histopathol; 2014 Jun; 29(6):777-83. PubMed ID: 24346847
[TBL] [Abstract][Full Text] [Related]
4. Telomerase expression in normal endometrium, endometrial hyperplasia, and endometrial adenocarcinoma.
Shroyer KR; Stephens JK; Silverberg SG; Markham N; Shroyer AL; Wilson ML; Enomoto T
Int J Gynecol Pathol; 1997 Jul; 16(3):225-32. PubMed ID: 9421087
[TBL] [Abstract][Full Text] [Related]
5. IMMUNOHISTOCHEMISTRY IN ENDOMETRIAL HYPERPLASIA AND ENDOMETRIAL ADENOCARCINOMA.
Socolov D; Socolov R; Lupascu IA; Rugina V; Gabia O; Garauleanu DM; Carauleanu A
Rev Med Chir Soc Med Nat Iasi; 2016; 120(2):355-62. PubMed ID: 27483717
[TBL] [Abstract][Full Text] [Related]
6. [Expression of beta-catenin, Glut-1, PTEN proteins in uterine endometrioid adenocarcinoma and its precursor lesions].
Xiong Y; Xiong YY; Zhou YF
Zhonghua Bing Li Xue Za Zhi; 2009 Sep; 38(9):594-9. PubMed ID: 20079187
[TBL] [Abstract][Full Text] [Related]
7. Immunolocalization of ERK1/2 and p-AKT in normal endometrium, endometrial hyperplasia, and early and advanced stage endometrioid endometrial adenocancer and their prognostic significance in malignant group.
Gungorduk K; Ertas IE; Sahbaz A; Ozvural S; Sarica Y; Ozdemir A; Sayhan S; Gokcu M; Yilmaz B; Sanci M; Inan S; Harma M; Yildirim Y
Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():147-52. PubMed ID: 24965996
[TBL] [Abstract][Full Text] [Related]
8. Expression and significance of beta-catenin, Glut-1 and PTEN in proliferative endometrium, endometrial intraepithelial neoplasia and endometrioid adenocarcinoma.
Xiong Y; Xiong YY; Zhou YF
Eur J Gynaecol Oncol; 2010; 31(2):160-4. PubMed ID: 20527231
[TBL] [Abstract][Full Text] [Related]
9. Heart and Neural Crest Derivatives Expressed Transcript 2 (HAND2): a novel biomarker for the identification of atypical hyperplasia and Type I endometrial carcinoma.
Buell-Gutbrod R; Cavallo A; Lee N; Montag A; Gwin K
Int J Gynecol Pathol; 2015 Jan; 34(1):65-73. PubMed ID: 25473755
[TBL] [Abstract][Full Text] [Related]
10. Gain of OGP, an estrogen-regulated oviduct-specific glycoprotein, is associated with the development of endometrial hyperplasia and endometrial cancer.
Woo MM; Alkushi A; Verhage HG; Magliocco AM; Leung PC; Gilks CB; Auersperg N
Clin Cancer Res; 2004 Dec; 10(23):7958-64. PubMed ID: 15585630
[TBL] [Abstract][Full Text] [Related]
11. The role of immunohistochemical adrenomedullin and Bcl-2 expression in development of type-1 endometrial adenocarcinoma: Adrenomedullin expression in endometrium.
Bozkurt KK; Yalçın Y; Erdemoğlu E; Tatar B; Erdemoğlu E; Çerçi SS; Çiriş İM; Başpınar Ş; Uğuz A; Kapucuoğlu N
Pathol Res Pract; 2016 May; 212(5):450-5. PubMed ID: 26972419
[TBL] [Abstract][Full Text] [Related]
12. Expression of nm23 in normal, hyperplastic and neoplastic endometrial tissues.
Brustmann H; Naudé S
Pathol Res Pract; 1999; 195(12):829-34. PubMed ID: 10631718
[TBL] [Abstract][Full Text] [Related]
13. [Expression and relationship of Ezh2, Runx3 and caspase-3 in endometrial adenocarcinoma].
Guo ZL; Chen K; Wang XQ; Hu W
Zhonghua Bing Li Xue Za Zhi; 2011 Jun; 40(6):387-91. PubMed ID: 21914347
[TBL] [Abstract][Full Text] [Related]
14. Endometrial expression of Cyr61: a marker of estrogenic activity in normal and abnormal endometrium.
MacLaughlan SD; Palomino WA; Mo B; Lewis TD; Lininger RA; Lessey BA
Obstet Gynecol; 2007 Jul; 110(1):146-54. PubMed ID: 17601910
[TBL] [Abstract][Full Text] [Related]
15. Expression of hyaluronic acid and its receptors, CD44s and CD44v6, in normal, hyperplastic, and neoplastic endometrium.
Afify AM; Craig S; Paulino AF; Stern R
Ann Diagn Pathol; 2005 Dec; 9(6):312-8. PubMed ID: 16308159
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical analysis of CD44s and CD44v6 in endometriosis and adenomyosis : comparison with normal, hyperplastic, and malignant endometrium.
Lin Z; Cho S; Jeong H; Kim H; Kim I
J Korean Med Sci; 2001 Jun; 16(3):317-22. PubMed ID: 11410693
[TBL] [Abstract][Full Text] [Related]
17. Significance of matrix metalloproteinase-7 [correction of matrix metalloproteinase-2], -11 and tissue inhibitor of metalloproteinase-1 expression in normal, hyperplastic and neoplastic endometrium.
Obokata A; Watanabe J; Nishimura Y; Arai T; Kawaguchi M; Kuramoto H
Anticancer Res; 2007; 27(1A):95-105. PubMed ID: 17352221
[TBL] [Abstract][Full Text] [Related]
18. GLUT-1 is preferentially expressed in atypical endometrial hyperplasia and endometrial adenocarcinoma.
Ashton-Sager A; Paulino AF; Afify AM
Appl Immunohistochem Mol Morphol; 2006 Jun; 14(2):187-92. PubMed ID: 16785788
[TBL] [Abstract][Full Text] [Related]
19. [Expressions of aromatase protein and sex hormone receptor in endometrial lesions].
Ma XX; Zhang SL; Gao S; Lu JM; Dong F
Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):395-8. PubMed ID: 16831363
[TBL] [Abstract][Full Text] [Related]
20. Tenascin expression in normal, hyperplastic, and neoplastic endometrium.
Sedele M; Karaveli S; Peştereli HE; Simşek T; Elpek G; Uner M; Sargin CF
Int J Gynecol Pathol; 2002 Apr; 21(2):161-6. PubMed ID: 11917226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
